CTI CAPITAL
CTI Capital is a venture capital fund that invests in development-stage, Canadian life sciences companies.
CTI CAPITAL
Industry:
Biotechnology Pharmaceutical Venture Capital
Founded:
1987-01-01
Status:
Active
Technology used in webpage:
SPF Domain Not Resolving Euro Microsoft Exchange Online Office 365 Mail Google Maps GoDaddy DNS Google Maps API GoDaddy
Current Advisors List
Robert Lacroix Board of Directors @ CTI Capital Board_member
Current Employees Featured
Shermaine Tilley
Shermaine Tilley Partner @ CTI Capital Partner
Guylaine Couillard
Guylaine Couillard Administrative Assistant @ CTI Capital Administrative Assistant
Franรงois Soto
Franรงois Soto Research Analyst, Equity Market. @ CTI Capital Research Analyst, Equity Market.
Bernard Casimir
Bernard Casimir Registered Representative @ CTI Capital Registered Representative
Ivan Greenstein
Ivan Greenstein Institutional Representative, Fixed Income @ CTI Capital Institutional Representative, Fixed Income
Yuan Li
Yuan Li Administrative Assistant @ CTI Capital Administrative Assistant
Sophie Buu
Sophie Buu Director Administration and Regulation @ CTI Capital Director Administration and Regulation
Stephan Buu
Stephan Buu Portfolio Manager, Global Markets @ CTI Capital Portfolio Manager, Global Markets
Mark Chadakhtzian
Mark Chadakhtzian Chief Financial Officer and Chief Compliance Officer @ CTI Capital Chief Financial Officer and Chief Compliance Officer
Pierre-Olivier Boulanger
Pierre-Olivier Boulanger Research Analyst, Fixed Income @ CTI Capital Research Analyst, Fixed Income
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-01-18 | Wattio | CTI Capital investment in Venture Round - Wattio | 170 K EUR |
2014-07-14 | Xagenic | CTI Capital investment in Series B - Xagenic | 25.5 M USD |
2012-01-30 | Xagenic | CTI Capital investment in Series A - Xagenic | 10 M USD |
2011-09-22 | Zymeworks | CTI Capital investment in Venture Round - Zymeworks | 8.1 M USD |
2009-08-10 | Enobia Pharma | CTI Capital investment in Series C - Enobia Pharma | 50 M USD |
2009-06-29 | Zymeworks | CTI Capital investment in Venture Round - Zymeworks | 3.2 M USD |
2000-03-31 | BeXcom | CTI Capital investment in Venture Round - BeXcom | 75 M USD |